Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINC1 | P01008 | 3/20 | 0.50 |
| ▸ | F10 | P00742 | 5/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | FGF1 | P05230 | 5/20 | 0.44 |
| ▸ | HPSE | Q9Y251 | 8/20 | 0.39 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.38 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.38 |
| ▸ | CCL2 | P13500 | 1/20 | 0.38 |
| ▸ | CCL5 | P13501 | 1/20 | 0.38 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.38 |
| ▸ | FGF2 | P09038 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15893508 | 0.92 | SERPINC1 (0.51) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL14959633 | 0.90 | SERPINC1 (0.57) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014801 | 0.85 | SERPINC1 (0.46) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014812 | 0.85 | SERPINC1 (0.46) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014820 | 0.85 | SERPINC1 (0.46) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014814 | 0.83 | SERPINC1 (0.42) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014821 | 0.82 | SERPINC1 (0.43) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014807 | 0.82 | SERPINC1 (0.43) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014819 | 0.82 | SERPINC1 (0.43) | SERPINC1F10F2FGF1HPSE | |
| SCHEMBL10014427 | 0.82 | SERPINC1 (0.43) | SERPINC1F10F2FGF1HPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120039843-A1 | CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE | N.V. ORGANON (NL) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120039843-A1 | CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE | SERPINC1, SELP, F13B | SERPINC1 1/4885F10 106/4885F2 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.